• Mashup Score: 3

    Submit your picks! | NephMadness 2023 | #NephMadness | #CardiacDevices Selection Committee Member: Nisha Bansal @NishaKidneyDoc Nisha Bansal is an Associate Professor and the Arthur Stach Family En…

    Tweet Tweets with this article
    • #NephMadness #CardioRenal Region Part II 🫀🫘 #CardiacDevices in AKI vs Cardiac Devices in ESKD Learn about IABP, Impella, TandemHeart, ECMO, LVAD, axial vs centrifugal flow, INTERMACS, EUROMACS... https://t.co/vyeu6B3MwR @anna_burgner @nepherson @NishaKidneyDoc https://t.co/75pyqOJ7W0

  • Mashup Score: 0

    Join us for dinner and conversation with our APAC PA panel on best practice collaboration with APPs in optimal team-based cardiovascular practice. Topic: CV and Renal risk reduction in diabetes: reviewing finerenone in the Fidelio and Figaro trials; Presenter: Sanjay Sharma M.D.

    Tweet Tweets with this article
    • Link to register here: https://t.co/lRLqrjIrtw Network with #cardiology #physicianassociates 03/05 6:30PM CST, learn about #cardiorenal protection and optimal CV #teambasedcare with #APPs #accfit #acccvt #NPs #PharmD @drsharma815 @BayerPharma @DrMarthaGulati @AAPAorg https://t.co/5duC0bI8Gh https://t.co/lXNa0dbVrI

  • Mashup Score: 6

    Renal dysfunction is one of the strongest predictors of outcome in heart failure. Several studies have revealed that both reduced perfusion and increased congestion (and central venous pressure) contribute to worsening renal function in heart failure. This paper proposes a novel factor in the link b …

    Tweet Tweets with this article
    • RT @NephroP: Renal tamponade in #cardiorenal states Click 'ALT' for figure description 🔗https://t.co/9IHgHeF57v Persistent interstitial ede…

  • Mashup Score: 1

    COURSE DIRECTORSImad Hussain, MD, FACCProgram Director, Advanced Heart Failure & Transplant Cardiology FellowshipAssistant Professor of Cardiology, Academic InstituteAssistant Clinical Member, Research InstituteHouston MethodistWeill Cornell Medical CollegeJu H. Kim, MD, FACC, FHFSAAdvanced Heart Failure and Transplant CardiologyAssociate Program Director, Cardiovascular Disease…

    Tweet Tweets with this article
    • CALLING ALL HEALTHCARE PROFESSIONALS! Join for #HHFS2023 on Feb 4 @TXMedCenter! Hear from @RayanYousefzai, as he discusses the impact and management of #Cardiorenal Syndrome in #HeartFailure. Register now at https://t.co/3rWIicGtKZ! @WilliamZoghbi @NadeenFaza @txchapteracc #CME https://t.co/k3uX1h7CkF

  • Mashup Score: 4

    Submit your picks! | NephMadness 2022 | #NephMadness | #CardioRenal Selection Committee Member: Nisha Bansal @NishaKidneyDoc Nisha Bansal is an Associate Professor and the Arthur Stach Family Endow…

    Tweet Tweets with this article
    • Congrats @hellokidneymd! https://t.co/A5tkW7Ce76 #NephMadness #KidneyWk #CardioRenal @DrFlashHeart @NishaKidneyDoc @HeartDocSadiya https://t.co/4sO91rGFG0 https://t.co/pKk3f8sNFb

  • Mashup Score: 6

    Direct oral anticoagulants (DOAC) have progressively replaced vitamin K antagonists (VKA) for stroke prevention in patients with non-valvular atrial fibrillation (AF). DOACs cause fewer bleeding complications but other advantages of DOACs, particularly related to kidney outcomes, remain inconclusive. We studied the risks of CKD progression and AKI following DOAC and VKA administration for…

    Tweet Tweets with this article
    • Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants https://t.co/TbYJMqt5Cy #OpenAccess @MarcoTrevi6 @CMClase @FuEdouard @jjcarrero1 #VisualAbstract #cardiorenal https://t.co/9fDSmV3pL9